Sanofi Consumer Healthcare India Limited (SANOFICONR) — Financial Results | 30 April 2026

StockFin.ai

Try Free

Sanofi Consumer Healthcare India Limited reported Q1 2026 revenue of ₹2,292 MN, up 33% year-on-year, with net profit at ₹678 MN, reflecting a 36% increase, driven by domestic sales growth of 15.5% and export surge of 144% following product relaunches.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SANOFICONR ✨ Ask AI About This

About Sanofi Consumer Healthcare India Limited (SANOFICONR)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹11,212.23 Cr P/E: 43.5

View full SANOFICONR stock details →

📡 Get AI alerts when SANOFICONR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SANOFICONR — Free

💡 Ask AI about this filing

"How does this financial results affect Sanofi Consumer Healthcare India Limited's outlook?" "What did Sanofi Consumer Healthcare India Limited announce on 30 April 2026?" "Is this positive or negative for SANOFICONR?"

Ask AI Free →

📊 More SANOFICONR filings

See all SANOFICONR filings →

🔥 Also filed on 30 April 2026

PRAXIS Praxis Home Retail Limited Announcement PRUDENT Prudent Corporate Advisory Services Limited Financial Results PREMIERPOL Premier Polyfilm Limited Insider Trading PSPPROJECT PSP Projects Limited Financial Results PSPPROJECT PSP Projects Limited Financial Results RAILTEL Railtel Corporation Of India Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SANOFICONR files new disclosures

Track SANOFICONR filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SANOFICONR — Free

Free account · 2 AI queries/day